Andrew Z. Wang

Andrew Z. Wang, M.D., is a tenured Professor and holds the A. Kenneth Pye Professorship in Cancer Research at the University of Texas Southwestern. He serves as Vice Chair for Translational Research and Commercialization in the Department of Radiation Oncology, having joined UTSW in August 2021. Previously, he held faculty positions at the University of North Carolina, where he rose from Assistant to Tenured Professor.

Dr. Wang's research integrates biomedical engineering with oncology to develop innovative cancer diagnostics and therapeutics. His work focuses on:

• Nanotechnology-enabled drug delivery systems
• Cancer immunotherapy and vaccine development
• Biomaterial applications in oncology
• Liquid biopsy technologies for treatment monitoring
• Radiotherapy-enhancing strategies

His 128+ publications demonstrate consistent focus on translational nanomedicine, with recent works advancing combination therapies (chemoradiation-immunotherapy), 3D-printed medical devices, and machine learning applications in oncology. Clinical publications emphasize optimizing radiation techniques for genitourinary/gastrointestinal cancers.

Major scientific recognitions include:

• Fellow of the American Association for the Advancement of Science (AAAS)
• Fellow of the American Institute for Medical and Biological Engineering (AIMBE)
• Fellow of the American Society for Clinical Investigation (ASCI)
• A. Kenneth Pye Professorship in Cancer Research

Dr. Wang leads a prolific research program generating 38 patents and founding three biotechnology startups. Clinically, he specializes in advanced radiation techniques (IMRT, SBRT, brachytherapy) for genitourinary and gastrointestinal malignancies.